Respiratory Solutions
Helping Providers Manage Acute Respiratory Tract Infections
QDx provides molecular respiratory syndromic panels to support your clinical decision making when managing seasonal acute respiratory tract infections. Testing is based on accurate, rapid and reliable FDA approved methodologies so you can start patient treatment sooner while maintaining responsible antibiotic stewardship.
QDx provides molecular respiratory syndromic panels to support your clinical decision making when managing seasonal acute respiratory tract infections. Testing is based on accurate, rapid and reliable methodologies so you can start patient treatment sooner while maintaining responsible antibiotic stewardship.
Turn Around Time — 24 hours
COVID-19
- SARS-CoV-2-RNA (COVID-19)
QDx Respiratory Panels provide the detection and identification of specific viral and bacterial nucleic acids from individuals exhibiting signs and symptoms of respiratory infection. The panel is used for the detection of the following respiratory pathogens:
Turn Around Time — 24 hours
Provides detection of Group A Streptococcus (Group A β-hemolytic Streptococcus, Strep A) in throat swab specimens from patients with signs and symptoms of pharyngitis.
Turn Around Time — 24 hours
- Realtime polymerase chain reaction (PCR) testing method
